The evaluation of relationship between polypharmacy and anticholinergic burden scales.
Anticholinergic burden scales
Elderly
Polypharmacy
Journal
Northern clinics of Istanbul
ISSN: 2536-4553
Titre abrégé: North Clin Istanb
Pays: Turkey
ID NLM: 101684520
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
06
2020
accepted:
05
11
2020
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
15
4
2021
Statut:
epublish
Résumé
Polypharmacy and anticholinergic burden are the indicators for the evaluation of the quality of pharmacotherapy in older adults. The aim of this study was to consider which anticholinergic burden scales are more related with polypharmacy among older patients. Four hundred and twenty older adults were evaluated retrospectively in this cross-sectional study. The patient's demographic data, comorbidities, the drugs, and number of drugs were recorded. Anticholinergic burden scales were calculated by a tool named anticholinergic burden calculator. The participants' mean age was 73.08±8.71. The prevalence of polypharmacy was 32.14%. The highest relationship with polypharmacy was observed for drug burden index (DBI) (odds ratio 10.87, p<0.001). Our study demonstrated that polypharmacy and DBI scores were more related than other anticholinergic burden scales in older adults.
Identifiants
pubmed: 33851077
doi: 10.14744/nci.2020.17136
pii: NCI-8-139
pmc: PMC8039107
doi:
Types de publication
Journal Article
Langues
eng
Pagination
139-144Informations de copyright
Copyright: © 2021 by Istanbul Northern Anatolian Association of Public Hospitals.
Déclaration de conflit d'intérêts
Conflict of Interest: No conflict of interest was declared by the authors.
Références
J Am Geriatr Soc. 2015 Oct;63(10):2120-4
pubmed: 26480974
Clin Interv Aging. 2018 Oct 04;13:1899-1905
pubmed: 30323576
J Clin Psychiatry. 2001;62 Suppl 21:11-4
pubmed: 11584981
J Clin Pharmacol. 2006 Dec;46(12):1481-6
pubmed: 17101747
Eur J Clin Pharmacol. 2013 Jul;69(7):1485-96
pubmed: 23529548
Drugs Aging. 2014 Jan;31(1):33-45
pubmed: 24234805
J Am Geriatr Soc. 2012 Apr;60(4):616-31
pubmed: 22376048
Clin Interv Aging. 2018 Apr 09;13:607-613
pubmed: 29674846
Pharmacotherapy. 2005 Nov;25(11):1592-601
pubmed: 16232021
J R Coll Physicians Edinb. 2015;45(2):108-13
pubmed: 26181524
Drugs Aging. 2018 Jun;35(6):523-538
pubmed: 29736815
J Am Geriatr Soc. 2008 Jul;56(7):1333-41
pubmed: 18510583
Intern Med J. 2013 Aug;43(8):912-8
pubmed: 23734965
Pharmacol Res Perspect. 2017 May 31;5(3):e00321
pubmed: 28603638
Arch Intern Med. 2008 Mar 10;168(5):508-13
pubmed: 18332297
Expert Opin Drug Saf. 2014 Jan;13(1):57-65
pubmed: 24073682
J Clin Pharmacol. 2011 Feb;51(2):256-63
pubmed: 20489026
J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):160-5
pubmed: 19770163
Neurol Sci. 2009 Apr;30(2):87-92
pubmed: 19229475
J Am Geriatr Soc. 2015 Jan;63(1):85-90
pubmed: 25597560
Arch Intern Med. 2007 Apr 23;167(8):781-7
pubmed: 17452540
Drugs Aging. 2009;26(6):493-503
pubmed: 19591524
Am J Geriatr Psychiatry. 2017 May;25(5):531-540
pubmed: 28233606
Farm Hosp. 2017 Sep 01;41(5):647-648
pubmed: 28847259
Br J Clin Pharmacol. 2015 Nov;80(5):1169-75
pubmed: 25923961
J Am Geriatr Soc. 2008 Dec;56(12):2203-10
pubmed: 19093918
BMJ Open. 2018 Mar 14;8(3):e020270
pubmed: 29540422
Arch Intern Med. 2003 Dec 8-22;163(22):2716-24
pubmed: 14662625
Age Ageing. 2014 Sep;43(5):604-15
pubmed: 25038833
Arch Gerontol Geriatr. 2016 Jan-Feb;62:1-8
pubmed: 26518612
Psychogeriatrics. 2013 Mar;13(1):17-24
pubmed: 23551407
BMJ. 2006 Feb 25;332(7539):455-9
pubmed: 16452102
Dement Geriatr Cogn Disord. 2011;31(3):173-8
pubmed: 21389718
Fam Pract. 2007 Feb;24(1):14-9
pubmed: 17164234
Clin Interv Aging. 2019 Nov 08;14:1963-1974
pubmed: 31806952